Pacific Biosciences Of California (PACB) Free Cash Flow (2010 - 2026)

Pacific Biosciences Of California's Free Cash Flow history runs 17 years deep, the most recent figure standing at -$47.7 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 5.04% year-over-year to -$47.7 million; the TTM figure through Mar 2026 stood at -$116.2 million (up 34.76% YoY), while the FY2025 annual figure was -$113.9 million, up 46.33% from the prior year.
• Free Cash Flow was -$47.7 million for Q1 2026 at Pacific Biosciences Of California, down from -$19.9 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$18.6 million in Q3 2025 to a low of -$98.4 million in Q1 2023.
• Historically, Free Cash Flow has averaged -$54.2 million across 5 years, with a median of -$55.7 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Free Cash Flow sank 273.72% in 2022, then jumped 58.32% in 2025.
• A 5-year view of Free Cash Flow shows it stood at -$65.5 million in 2022, then rose by 8.99% to -$59.6 million in 2023, then surged by 45.85% to -$32.3 million in 2024, then soared by 38.23% to -$19.9 million in 2025, then tumbled by 139.51% to -$47.7 million in 2026.
• The last three Free Cash Flow figures came in at -$47.7 million (Q1 2026), -$19.9 million (Q4 2025), and -$18.6 million (Q3 2025), per Business Quant data.